Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
Circ Res. 2011 Sep 2;109(6):680-6. doi: 10.1161/CIRCRESAHA.111.248161. Epub 2011 Jul 21.
Thoracic aortic aneurysms leading to acute aortic dissections (TAAD) can be inherited in families in an autosomal dominant manner. As part of the spectrum of clinical heterogeneity of familial TAAD, we recently described families with multiple members that had TAAD and intracranial aneurysms or TAAD and intracranial and abdominal aortic aneurysms inherited in an autosomal dominant manner.
To identify the causative mutation in a large family with autosomal dominant inheritance of TAAD with intracranial and abdominal aortic aneurysms by performing exome sequencing of 2 distantly related individuals with TAAD and identifying shared rare variants.
A novel frame shift mutation, p. N218fs (c.652delA), was identified in the SMAD3 gene and segregated with the vascular diseases in this family with a logarithm of odds score of 2.52. Sequencing of 181 probands with familial TAAD identified 3 additional SMAD3 mutations in 4 families, p.R279K (c.836G>A), p.E239K (c.715G>A), and p.A112V (c.235C>T), resulting in a combined logarithm of odds score of 5.21. These 4 mutations were notably absent in 2300 control exomes. SMAD3 mutations were recently described in patients with aneurysms osteoarthritis syndrome and some of the features of this syndrome were identified in individuals in our cohort, but these features were notably absent in many SMAD3 mutation carriers.
SMAD3 mutations are responsible for 2% of familial TAAD. Mutations are found in families with TAAD alone, along with families with TAAD, intracranial aneurysms, abdominal aortic and bilateral iliac aneurysms segregating in an autosomal dominant manner.
导致急性主动脉夹层(TAAD)的胸主动脉瘤可在常染色体显性遗传的家族中遗传。作为家族性 TAAD 临床异质性谱的一部分,我们最近描述了多个家族,这些家族中多个成员存在 TAAD 伴颅内动脉瘤或 TAAD 伴颅内、腹主动脉和双侧髂动脉瘤,呈常染色体显性遗传。
通过对 2 名具有 TAAD 和颅内动脉瘤的远距离相关个体进行外显子组测序,并确定共享的罕见变异,来鉴定一个具有常染色体显性遗传、TAAD 伴颅内和腹主动脉瘤的大型家族的致病突变。
在一个具有常染色体显性遗传的家族中,发现了一个新的移码突变,p. N218fs(c.652delA),该突变位于 SMAD3 基因中,并与该家族的血管疾病相分离,对数优势评分为 2.52。对 181 名具有家族性 TAAD 的先证者进行测序,在 4 个家族中发现了另外 3 个 SMAD3 突变,分别为 p.R279K(c.836G>A)、p.E239K(c.715G>A)和 p.A112V(c.235C>T),合并对数优势评分为 5.21。这些突变在 2300 个对照外显子中明显不存在。SMAD3 突变最近在伴有动脉瘤骨关节炎综合征的患者中被描述,我们队列中的一些个体存在该综合征的一些特征,但在许多 SMAD3 突变携带者中明显不存在这些特征。
SMAD3 突变占家族性 TAAD 的 2%。突变存在于仅伴有 TAAD 的家族中,也存在于伴有 TAAD、颅内动脉瘤、腹主动脉和双侧髂动脉瘤且呈常染色体显性遗传的家族中。